Ligand tunnels in T. brucei and human CYP51: Insights for parasite-specific drug design

Background - Cytochrome P450 sterol 14α-demethylase (CYP51) is an essential enzyme for sterol biosynthesis and a target for anti-parasitic drug design. However, the design of parasite-specific drugs that inhibit parasitic CYP51 without severe side effects remains challenging. The active site of CYP5...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yu, Xiaofeng (VerfasserIn) , Nandekar, Prajwal (VerfasserIn) , Mustafa, Ghulam (VerfasserIn) , Cojocaru, Vlad (VerfasserIn) , Lepesheva, Galina I. (VerfasserIn) , Wade, Rebecca C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 October 2015
In: Biochimica et biophysica acta
Year: 2016, Jahrgang: 1860, Heft: 1, Part A, Pages: 67-78
ISSN:1878-2434
DOI:10.1016/j.bbagen.2015.10.015
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.bbagen.2015.10.015
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0304416515002871
Volltext
Verfasserangaben:Xiaofeng Yu, Prajwal Nandekar, Ghulam Mustafa, Vlad Cojocaru, Galina I. Lepesheva, Rebecca C. Wade

MARC

LEADER 00000caa a2200000 c 4500
001 1724722506
003 DE-627
005 20230427070033.0
007 cr uuu---uuuuu
008 200714s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.bbagen.2015.10.015  |2 doi 
035 |a (DE-627)1724722506 
035 |a (DE-599)KXP1724722506 
035 |a (OCoLC)1341345436 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Yu, Xiaofeng  |e VerfasserIn  |0 (DE-588)1082245984  |0 (DE-627)847245705  |0 (DE-576)455278393  |4 aut 
245 1 0 |a Ligand tunnels in T. brucei and human CYP51  |b Insights for parasite-specific drug design  |c Xiaofeng Yu, Prajwal Nandekar, Ghulam Mustafa, Vlad Cojocaru, Galina I. Lepesheva, Rebecca C. Wade 
264 1 |c 19 October 2015 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.07.2020 
520 |a Background - Cytochrome P450 sterol 14α-demethylase (CYP51) is an essential enzyme for sterol biosynthesis and a target for anti-parasitic drug design. However, the design of parasite-specific drugs that inhibit parasitic CYP51 without severe side effects remains challenging. The active site of CYP51 is situated in the interior of the protein. Here, we characterize the potential ligand egress routes and mechanisms in Trypanosoma brucei and human CYP51 enzymes. - Methods - We performed Random Acceleration Molecular Dynamics simulations of the egress of four different ligands from the active site of models of soluble and membrane-bound T. brucei CYP51 and of soluble human CYP51. - Results - In the simulations, tunnel 2f, which leads to the membrane, was found to be the predominant ligand egress tunnel for all the ligands studied. Tunnels S, 1 and W, which lead to the cytosol, were also used in T. brucei CYP51, whereas tunnel 1 was the only other tunnel used significantly in human CYP51. The common tunnels found previously in other CYPs were barely used. The ligand egress times were shorter for human than T. brucei CYP51, suggesting lower barriers to ligand passage. Two gating residues, F105 and M460, in T. brucei CYP51 that modulate the opening of tunnels 2f and S were identified. - Conclusions - Although the main egress tunnel was the same, differences in the tunnel-lining residues, ligand passage and tunnel usage were found between T. brucei and human CYP51s. - General Significance - The results provide a basis for the design of selective anti-parasitic agents targeting the ligand tunnels. 
650 4 |a CYP51 
650 4 |a Cytochrome P450 
650 4 |a Ligand access and egress 
650 4 |a Membrane-bound protein 
650 4 |a Random acceleration molecular dynamics 
650 4 |a Sterol 14α-demethylase 
700 1 |a Nandekar, Prajwal  |e VerfasserIn  |4 aut 
700 1 |a Mustafa, Ghulam  |e VerfasserIn  |4 aut 
700 1 |a Cojocaru, Vlad  |e VerfasserIn  |4 aut 
700 1 |a Lepesheva, Galina I.  |e VerfasserIn  |4 aut 
700 1 |a Wade, Rebecca C.  |e VerfasserIn  |0 (DE-588)102801774X  |0 (DE-627)730136000  |0 (DE-576)276591402  |4 aut 
773 0 8 |i Enthalten in  |t Biochimica et biophysica acta  |d Amsterdam [u.a.] : Elsevier, 1947  |g 1860(2016), 1, Part A, Seite 67-78  |h Online-Ressource  |w (DE-627)253779626  |w (DE-600)1460387-1  |w (DE-576)072793821  |x 1878-2434  |7 nnas  |a Ligand tunnels in T. brucei and human CYP51 Insights for parasite-specific drug design 
773 1 8 |g volume:1860  |g year:2016  |g number:1, Part A  |g pages:67-78  |g extent:11  |a Ligand tunnels in T. brucei and human CYP51 Insights for parasite-specific drug design 
856 4 0 |u https://doi.org/10.1016/j.bbagen.2015.10.015  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0304416515002871  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200714 
993 |a Article 
994 |a 2015 
998 |g 102801774X  |a Wade, Rebecca C.  |m 102801774X:Wade, Rebecca C.  |d 140000  |e 140000PW102801774X  |k 0/140000/  |p 6  |y j 
999 |a KXP-PPN1724722506  |e 3724262906 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1016/j.bbagen.2015.10.015"],"eki":["1724722506"]},"physDesc":[{"extent":"11 S."}],"note":["Gesehen am 14.07.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"title":[{"subtitle":"BBA ; international journal of biochemistry, biophysics and molecular biology","title":"Biochimica et biophysica acta","title_sort":"Biochimica et biophysica acta"}],"recId":"253779626","origin":[{"dateIssuedKey":"1947","publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1947-2016","publisher":"Elsevier"}],"disp":"Ligand tunnels in T. brucei and human CYP51 Insights for parasite-specific drug designBiochimica et biophysica acta","language":["eng"],"name":{"displayForm":["ed. board W. T. Astbury [u.a.]"]},"titleAlt":[{"title":"BBA"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1878-2434"],"eki":["253779626"],"zdb":["1460387-1"]},"note":["Gesehen am 14.10.2020","Bis 2016 einzelne Bände zugleich Bände der Sektionen"],"part":{"issue":"1, Part A","pages":"67-78","year":"2016","volume":"1860","extent":"11","text":"1860(2016), 1, Part A, Seite 67-78"},"pubHistory":["1.1947 - 1826.2012; Vol. 1827.2013 - 1866.2016"]}],"person":[{"roleDisplay":"VerfasserIn","display":"Yu, Xiaofeng","family":"Yu","given":"Xiaofeng","role":"aut"},{"roleDisplay":"VerfasserIn","given":"Prajwal","role":"aut","display":"Nandekar, Prajwal","family":"Nandekar"},{"roleDisplay":"VerfasserIn","given":"Ghulam","role":"aut","family":"Mustafa","display":"Mustafa, Ghulam"},{"roleDisplay":"VerfasserIn","given":"Vlad","role":"aut","family":"Cojocaru","display":"Cojocaru, Vlad"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Galina I.","display":"Lepesheva, Galina I.","family":"Lepesheva"},{"family":"Wade","display":"Wade, Rebecca C.","given":"Rebecca C.","role":"aut","roleDisplay":"VerfasserIn"}],"language":["eng"],"recId":"1724722506","origin":[{"dateIssuedDisp":"19 October 2015","dateIssuedKey":"2016"}],"title":[{"title_sort":"Ligand tunnels in T. brucei and human CYP51","title":"Ligand tunnels in T. brucei and human CYP51","subtitle":"Insights for parasite-specific drug design"}],"name":{"displayForm":["Xiaofeng Yu, Prajwal Nandekar, Ghulam Mustafa, Vlad Cojocaru, Galina I. Lepesheva, Rebecca C. Wade"]}} 
SRT |a YUXIAOFENGLIGANDTUNN1920